Moderna, Inc. to Join the NASDAQ-100 Index Beginning July 20, 2020
July 13 2020 - 10:33AM
Nasdaq (Nasdaq: NDAQ) today announced that Moderna, Inc. (Nasdaq:
MRNA), will become a component of the NASDAQ-100 Index® (Nasdaq:
NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the
NASDAQ-100 Ex-Tech Sector Index (Nasdaq: NDXX) prior to market open
on Monday, July 20, 2020.
Moderna, Inc. will replace CoStar Group, Inc. (Nasdaq: CSGP) in
the NASDAQ-100 Index®, the NASDAQ-100 Equal Weighted Index and the
NASDAQ-100 Ex-Tech Sector Index prior to market open on Monday,
July 20, 2020.
CoStar Group, Inc. will leave the N-100 due to reclassification
based on Industry Classification Benchmark (ICB) the globally
utilized standard for the categorization and comparison of
companies by industry and sector.
For more information Moderna, go to
https://www.modernatx.com/.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the
capital markets and other industries. Our diverse offering of data,
analytics, software and services enables clients to optimize and
execute their business vision with confidence. To learn more about
the company, technology solutions and career opportunities, visit
us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
financial product or an overall investment strategy. Neither The
NASDAQ OMX Group, Inc. nor any of its affiliates makes any
recommendation to buy or sell any financial product or any
representation about the financial condition of any company or
fund. Statements regarding Nasdaq’s proprietary indexes are not
guarantees of future performance. Actual results may differ
materially from those expressed or implied. Past performance is not
indicative of future results. Investors should undertake their own
due diligence and carefully evaluate companies before investing.
ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
NDAQO
Media Contact: Joseph
Christinat, Nasdaq Joseph.Christinat@nasdaq.com646 284
5920
Issuer & Investor Contact: Index Client
Services, NasdaqIndexservices@nasdaq.com
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Sep 2023 to Sep 2024